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Abstract
Whether purified HIV-1 virion cores are capable of reverse transcription or require uncoating to
be activated is currently controversial. To address this question we purified cores from a virus
culture and tested for the ability to generate authentic reverse transcription products. A dense
fraction (approximately 1.28 g/ml) prepared without detergent, possibly derived from disrupted
virions, was found to naturally occur as a minor sub-fraction in our preparations. Core-like
particles were identified in this active fraction by electron microscopy. We are the first to report
the detection of authentic strong-stop, first-strand transfer and full-length minus strand products
in this core fraction without requirement for an uncoating activity.
Findings
Deoxyribonucleotides added directly to HIV-1 virions are
incorporated into reverse transcription products [1-4].
This process, which is reported to disrupt the structure of
the core in virions [5], is referred to as natural endogenous
reverse transcription (NERT). Restructuring of the core
also occurs post-infection when the core enters the cyto-
plasm after fusion of the viral envelope and is referred to
as uncoating [6]. One commonly accepted interpretation
of NERT is that the observed virion disruption is analo-
gous to uncoating, and uncoating may be a requirement
for formation of an active reverse transcription complex
(RTC) (reviewed in [7]).
An alternative corollary of the ability of intact virions to
generate reverse transcription products is that cores puri-
fied from virions should be capable of reverse transcrip-
tion. Whilst purified cores have been shown to contain
reverse transcriptase [8-15], there is just one report of
cores generating authentic reverse transcription products,
but only when complemented with an "uncoating activ-
ity" from activated lymphocytes [16]. The question of the
biochemical state of virion core is of particular interest in
the light of recent reports of reverse transcription in cores
in vivo [17], and is important for our understanding of
early replication events. To explore this controversial
question, we used a modification of a commonly used
method of core purification. We demonstrated that cores
were able to generate authentic RT products without a
requirement for an uncoating activity, as described below.
Core fractions have reverse transcription activity
Isolation of morphologically intact cores from HIV-1 par-
ticles has been reportedly improved by "spin-thru" meth-
ods [8,18]. The principle of the method is that virions are
delipidated by brief sedimentation through a detergent
layer (0.03% Triton X-100). Free cores are separated from
virions and debris by subjecting them to equilibrium gra-
dient sedimentation on a continuous 20–60% Optiprep
density gradient for 20 h; cores sediment to the dense lay-
ers (1.24 – 1.28 g/ml).
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CXCR4-expressing HeLa cells (MAGI) and was subse-
quently concentrated by centrifugation on a 20% sucrose
cushion. We subjected two virus samples to 20–60%
Optiprep density gradient centrifugation for 20 h: one
with a detergent layer and a control without a detergent
layer. Fractions were obtained and assayed for capsid by
p24 ELISA and the ability to generate authentic reverse
transcription products (endogenous reverse transcription
or ERT activity). Interestingly, with repeated attempts we
were not able to detect ERT products using core fractions
prepared by brief passage through the detergent layer
(data not shown; Warrilow et al., manuscript under
review). However, a control preparation without a deter-
gent layer had capsid and ERT activity in fractions 7–9 (Fig
1A, B) corresponding to the reported buoyant density of
core (peak fraction 1.29 g/ml). A clear peak in activity was
seen, for example, fraction 8 contained 30-fold more ERT
activity than fraction 5. These three peak fractions repre-
sented 6% of total ERT activity of the fractions. This core
fraction was capable of first-strand transfer, and full-
length minus strand synthesis was also detectable above
background (Fig. 1B). However, the signal was not suffi-
cient to determine whether products indicating second-
strand transfer had been generated (data not shown). This
result was repeated in three separate experiments. Hence,
a naturally occurring core fraction was capable of
advanced reverse transcription.
Western analysis and electron microscopy of core fractions
Western analysis was performed on gradient fractions to
determine their composition. To provide sufficient mate-
rial for analyses, a fresh equilibrium gradient scaled up
approximately 20-fold was performed (Fig. 1C–F), and
fractions were then analyzed by western analysis using
purified anti-HIV-1 IgG (NIH AIDS Research and Refer-
ence Reagent Program). Multiple protein bands in the
peak virus fractions 3 and 4 (1.08 and 1.15 g/ml, respec-
tively) reacted with Gag proteins including capsid (Fig.
1C) as expected for intact virions. Only capsid protein was
detected in the denser fractions 8 and 9 (density 1.26 and
1.30 g/ml, respectively), confirming our ELISA results.
Reverse transcriptase was detected in these fractions by
colorimetric ELISA using homopolymeric template (Fig.
1D); matrix was detected by western analysis using a spe-
cific monoclonal antibody (data not shown) as has been
reported in other core preparations [11,13,14]; and gp41
was also detected in fractions 8 and 9 (Fig. 1E). A small
amount of gp41 has been reported in cores purified using
detergent [11]. In that study, gp41 was attributed to
microvesicles that co-purified with the cores. This seems
unlikely as microvesicles are generally less dense than core
[19]. Alternatively, due to our novel virus culture method,
our preparation may have contained a proportion of
immature virions which are known to a have a stable asso-
ciation between gp41 and immature cores [20].
Transmission electron microscopy (TEM) was used to fur-
ther characterize the denser fractions. Confirmation that
the denser fractions of the untreated sample contained
cores was obtained when numerous 80 – 100 nm cone
and rod-shaped structures were observed in these frac-
tions (Fig. 1F). No whole virions were observed. The
above data are consistent with dense fractions with capsid
and ERT activity which most likely contain biochemically
active cores.
We are the first to report the detection of authentic strong-
stop, first-strand transfer and full-length minus strand
products in a core fraction. This confirms our expecta-
tions, from observations of the NERT reaction, that core is
capable of reverse transcription, at least to full length
minus-strand synthesis. It confirms that the enzymatic
activities sufficient for reverse transcription are present in
the core. Our data also support the suggestion that core
may increase the effective concentration of components
important for reverse transcription reaction, facilitating
strand transfers and the efficiency of the overall reaction.
The density of core does not sterically block polymerase
elongation; however, we have no data as to the effect of
elongation on core structure and it could be that the elon-
gation of the polymerase results in shedding of capsid as
suggested by the effect of NERT on virion morphology [5].
Some cellular protein, perhaps the uncoating factor, may
assist the elongating complex to efficiently complete
reverse transcription.
Preparation of cores without detergent treatment to
remove the viral envelope would appear to be counterin-
tuitive. Interestingly, in support of our data, capsid pro-
tein has been reported in dense fractions of virions
subjected to equilibrium gradient ultracentrifugation
without prior detergent treatment [21], although the
reverse transcription capacity was not assessed. One expla-
nation for the presence of cores in our samples is that vir-
ions could have been gently disrupted by our culture and
purification method, as core release by damage to virions
has been reported [22]. We chose to amplify virus on
MAGI cells for 6 days prior to concentration on 20%
sucrose cushion (see supplementary methods). This
method may have been sufficiently disruptive to the enve-
lope to result in core release.
Our data conflict with these previous observations of a
requirement for an "uncoating activity" to activate reverse
transcription activity [16]. It is possible that cores pre-
pared using detergent methods require complementation
by a cell factor, perhaps an uncoating activity, to be acti-
vated. In contrast, we have found cores to be active forPage 2 of 5
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Analysis of core fractionsFigure 1
Analysis of core fractions. (A) Endogenous reverse transcriptase activity: strong-stop (squares), first-strand transfer (dia-
monds) and full-length targets (triangles) are shown. (B) p24 ELISA on fractions; inset shows the density of fractions calculated 
from weight (fractions 3–9 only are shown). Viral proteins were detected in HIV-1NL4.3 equilibrium gradient fractions 1–9 by 
western analysis using (C) anti-HIV-1 polyclonal antibody, (D) colorimetric reverse transcriptase ELISA using homoploymeric 
template (fractions 5–9 only are shown), and (E) anti-gp41 antibody. (F) Negative staining transmission electron microscopy of 
dense fractions showing four representative core-like structures. 100,000× magnification; bar indicates 50 nm. Please note, the 
fractions shown in A and B are from a separate preparation to those in C-E and hence fraction numbers do not directly corre-
spond [see Additional file 1 for complete methods].
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Retrovirology 2007, 4:77 http://www.retrovirology.com/content/4/1/77reverse transcription, at least making DNase I-resistant full
length minus-strand DNA, albeit inefficiently, without
requiring capsid release.
Our isolation of active cores without detergent treatment
was fortuitous and reproducible; however, the quantity of
the naturally-occurring core fraction varied from prepara-
tion to preparation. We, therefore, attempted to isolate
cores by a more reliable method. Due to the denaturing
effects of detergent, we attempted a number of other
methods (data not shown) such as freeze-thaw treatment
and exposure to β-cyclodextrin, which removes choles-
terol and leads to lipid bilayer breakdown [23]. To date
none of these methods has resulted in reliable isolation of
cores that are positive for ERT activity.
We have provided evidence for reverse transcription in a
core fraction, and previous detergent experiments also
suggest core structure is important for this process (War-
rilow et al., manuscript under review). Whilst our data
indicate a cell "uncoating activity" is not required to initi-
ate reverse transcription or generate some late products, it
is still consistent with a model in which the elongating
RTC formation requires a cellular factor(s), for regulation
of uncoating, or for completion of reverse transcription.
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